Discovery and Development Of The DPP‐4 Inhibitor Januvia™ (Sita‐Gliptin)

This chapter contains sections titled: Introduction DPP-4 Inhibition as a Therapy for Type 2 Diabetes: Identification of Key Determinants for Efficacy and Safety Medicinal Chemistry Program Synthetic and Manufacturing Routes to Sitagliptin Drug Product Development Clinical Studies Summary References